CTI Start-up Label for Numab, Qvanteq, SwissTV and Virometix

Three of the four companies are from the life sciences sector. The fourth start-up is active in the entertainment industry.

Numab, based in Wädenswil, is a Swiss biotech company that innovates and develops antibody-based therapeutics. A particular focus is given to the discovery of protein therapeutics against non-traditional antibody targets, such as complex membrane proteins. Numab’s proprietary discovery technology is particularly well suited to approach this class of drug-targets that formerly was inaccessible to most protein-binder platforms. All of the company’s founders have a proven track record in the biotech industry: They worked several years for Esbatech.

Qvanteq develops novel stent technologies to address and overcome the clinically adverse effects of today’s available coronary artery stents. A coronary stent is a small (metal) mesh tube which is being implanted into coronary arteries to prevent heart attacks. The company is a spin-off company from the Swiss Federal Institute of Technology (ETH) Zurich. It was founded in early 2009 and is held by private investors. The Headquarter is located at Technopark Zurich, Switzerland.

SwissTV operates the first video-on-demand service (VOD), with no subscription and no commitment. It’s easy to use interface comes in 4 languages. Thanks to contracts obtained in 2010 with the main film and television producers (Warner Bros, Universal, MGM, Sony, BBC, Arte, Discovery, MTV, etc.), the SwissTV catalogue contains about 4,000 titles. SwissTV is a Swiss company based in Geneva.

Virometix is a biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. The company has created a platform for manufacturing vaccines chemically. Such a manufacturing process is not only simpler and more cost-efficient but also safer. Virometix is a spin-out company from the University of Zurich and was founded in October 2009.

Companies are awarded with the CTI start-up label at the end of a process of three phases in which over forty experienced coaches guide start-up companies on their way to enter the market successfully and attract financing. Only the best of the start-ups entering this process will get the label at the end.